Pharmaids Pharmaceuticals Limited (BOM:524572)

Market Cap	1.50B
Revenue (ttm)	248.12M
Net Income (ttm)	-132.67M
Shares Out	35.27M
EPS (ttm)	-3.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,111
Average Volume	3,238
Open	44.25
Previous Close	44.25
Day's Range	42.13 - 46.99
52-Week Range	42.00 - 77.40
Beta	0.11
RSI	33.93
Earnings Date	Feb 12, 2026

About Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. The company offers pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile,pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine,2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino]thiophene-3-carbonitrile, 4-amino-2-methyl-1...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 28
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524572

Financial Performance

In 2024, Pharmaids Pharmaceuticals's revenue was 195.14 million, an increase of 27.54% compared to the previous year's 153.00 million. Losses were -107.77 million, 35.2% more than in 2023.